SCHEMBL1921676

SCHEMBL1921676

Nc1ccnc(-c2ncccn2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 5/20 0.44
NOS3 P29474 4/20 0.44
NOS1 P29475 3/20 0.44
PI4KA P42356 2/20 0.44
PI4KB Q9UBF8 2/20 0.44
PI4K2B Q8TCG2 1/20 0.44
PI4K2A Q9BTU6 1/20 0.44
HSP90AA1 P07900 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALOX15 P16050 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
PLAU P00749 2/20 0.37
NCF1 P14598 2/20 0.37
BACE1 P56817 2/20 0.37
F12 P00748 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.36
SCN9A Q15858 2/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27754726 0.92 HSP90AA1 (0.42) NOS2NOS3NOS1PI4KAPI4KB
SCHEMBL1414907 0.81 KDM4E (0.60) NOS2NOS3NOS1PI4KAPI4KB
SCHEMBL1828161 0.79 ADORA2A (0.53) HSP90AA1KDM4EL3MBTL1BACE1
SCHEMBL2415317 0.77 HSP90AA1 (0.41) NOS2NOS3NOS1PI4KAPI4KB
SCHEMBL7264629 0.75 KDM4E (0.49) NOS2NOS3NOS1PI4KAPI4KB
SCHEMBL12443811 0.75 MEN1 (0.48) KDM4EIRAK4TDP1
SCHEMBL1018167 0.75 NPC1 (0.47) HSP90AA1L3MBTL1SCN9A
SCHEMBL2069697 0.74 POLB (0.52) KDM4EALOX15L3MBTL1TDP1
SCHEMBL2068779 0.74 ALDH1A1 (0.56) KDM4EL3MBTL1TDP1
SCHEMBL11273216 0.74 ADORA3 (0.48) PI4KAPI4KBHSP90AA1ALOX15SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9216964-B2 Hedgehog pathway modulators NOVARTIS AG (CH) 2015-12-22 US disclosed
US-8975402-B2 HPLC method for the analysis of bosetan and related substances and use of these substances as reference standards and markers GENERICS [UK] LIMITED (GB) 2015-03-10 US disclosed
US-20130296333-A1 HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2013-11-07 US disclosed
US-8507491-B2 Compounds and compositions as hedgehog pathway inhibitors IRM LLC (BM) 2013-08-13 US disclosed
US-20110263853-A1 HPLC METHOD FOR THE ANALYSIS OF BOSETAN AND RELATED SUBSTANCES AND USE OF THESE SUBSTANCES AS REFERENCE STANDARDS AND MARKERS MYLAN INDIA PRIVATE LIMITED (IN) 2011-10-27 US disclosed
US-20110152282-A1 HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2011-06-23 US disclosed
EP-2328871-A2 HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2011-06-08 EP disclosed
WO-2010027746-A2 HEDGEHOG PATHWAY MODULATORS IRM LLC (BM) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130296333-A1 HEDGEHOG PATHWAY MODULATORS GLI1, SHH, SMO NOS2 3957/4885NOS3 4131/4885NOS1 4178/4885
US-20110152282-A1 HEDGEHOG PATHWAY MODULATORS GLI1, SHH, SMO NOS2 4272/4885NOS3 4294/4885NOS1 4455/4885
US-20110263853-A1 HPLC METHOD FOR THE ANALYSIS OF BOSETAN AND RELATED SUBSTANCES AND USE OF THESE SUBSTANCES AS REFERENCE STANDARDS AND MARKERS SHBG, PGF, NPPA NOS2 56/4885NOS3 33/4885NOS1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.